<DOC>
	<DOCNO>NCT00716924</DOCNO>
	<brief_summary>Primary Objective : To test 600 mg clopidogrel load dose administer ≥ 6 ≤ 24 hour prior PCI produce great decrease periprocedural release biochemical marker ( CK , CK-MB , troponin-T and/or I ) myocardial necrosis , compare 300 mg load dose , give ≥ 6 ≤ 24 hour prior PCI 600 mg load dose clopidogrel , administer immediately ( ≤ 45 minute ) PCI .</brief_summary>
	<brief_title>CASTLE ( Clopidogrel And Serum Troponin Level Elevation )</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Patients symptomatic coronary artery disease objective evidence ischemia ( eg , symptoms angina pectoris , positive stress test result dynamic electrocardiographic ( ECG ) change ) . Patients undergoing stent implantation Any known contraindication use aspirin clopidogrel . Patients receive clopidogrel within 10 day , thrombolytic within 24 hour receive oral anticoagulation therapy Elective administration IIb/IIIa inhibitor . Cardiogenic shock Acute MI &lt; 24 hour BP systolic &lt; 100 mmHg Left ventricular ejection fraction &lt; 30 % Heart failure , NYHA class III IV Severe renal insufficiency ( creatinine &gt; 3.0 mg/dL ) Platelet count &lt; 100,000/mm³ Target lesion venous bypass graft Target lesion chronic occlusion The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>